- Current report filing (8-K)
June 17 2009 - 5:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 17,
2009
BRUKER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other
jurisdiction
of incorporation)
|
|
000-30833
(Commission
File Number)
|
|
04-3110160
(IRS Employer
Identification No.)
|
40
Manning Road
Billerica, MA 01821
(Address of
principal executive offices)(Zip Code)
Registrants
telephone number, including area code:
(978) 663-3660
Check
the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the reporting obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act
o
Soliciting material pursuant
to Rule 14a-12 of the Exchange Act
o
Pre-commencement
communications pursuant to Rule 14d-2(b) Exchange Act
o
Pre-commencement
communications pursuant to Rule 13e-4(c) Exchange Act
Item 2.02 Results
of Operations and Financial Condition.
On June 17, 2009,
Bruker Corporation (the Company) will participate in investor meetings in New
York, hosted by Goldman Sachs. The
presentation materials, a copy of which are attached hereto as Exhibit 99.1,
on slides 6, 7, 8 and 9 contain certain previously non-public information
relating to the performance of the Companys operating subsidiaries during the
fiscal year ended December 31, 2008, and their goals going forward.
The information in this Current
Report on Form 8-K, including
exhibits
attached hereto
and the information under Item 7.01 below,
is being furnished and shall not
be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that Section and shall not be deemed incorporated by
reference into any filing by the Company under the Securities Act of 1933, as
amended, or the Exchange Act, unless specifically identified therein as being
incorporated by reference therein.
Item 7.01 Regulation
FD Disclosure.
The information set forth in Item 2.02 is incorporated
herein in its entirety. The presentation
materials attached hereto as Exhibit 99.1 on slides 6, 7, 8 and 9 contain
certain previously non-public information relating to the Companys Scientific
Instruments Business and to its Bruker Advanced Supercon subsidiary.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. 99.1
June 17, 2009 PowerPoint Presentation
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
BRUKER CORPORATION
|
|
(Registrant)
|
|
|
Date: June 17,
2009
|
By:
|
/s/ William J. Knight
|
|
|
William J.
Knight
|
|
|
Chief
Financial Officer
|
3
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024